Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03050658 · ClinicalTrials.gov registry record
Bathing Babies and Allergy
A clinical trial, sponsored by University of Virginia.
- Completed
- Registry status
- 28
- Enrollment target
NCT03050658 is a clinical trial that has completed, run by University of Virginia. The registered enrollment target is 28 participants.
The verdict
NCT03050658 has completed, sponsored by University of Virginia.
- COMPLETED
- Registry status
- 28 participants
- Enrollment target
Study Summary
Atopic dermatitis (AD) is a chronic allergic skin disease with onset in early childhood and increasing prevalence in Westernized countries. Current well newborn guidelines for washing babies with soap were adopted by U.S. hospitals in the 1970s, before the rise in prevalence of allergic disease and AD (also called eczema). Increased transepidermal water-loss (TEWL) in newborn skin at 2 days of life was recently identified as a predictor of AD and allergy development by age 2 years. Risk for AD in babies was also linked to decreased skin colonization with certain skin microflora, such as staphylococcal organisms. Together, these data raise the question of whether newborn skincare guidelines have the potential to modify a baby's risk for allergy development. Our current practice of washing babies with soap may alter TEWL or other natural factors in skin that protect babies from development of AD and allergy. More knowledge is needed about the impact of infant skincare practices on allergy development. The objective of this pilot study is to determine the impact of a baby's first bath on his/her transepidermal water loss (TEWL) and skin microflora. Study procedures will include collection of TEWL measurements and skin swabs for skin microflora analysis pre/post first bath in healthy term newborns at UVA. This data will serve as preliminary data for future studies.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2017-02-07 |
| Est. Completion | 2021-05-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03050658
The ClinicalTrials.gov registry entry for NCT03050658 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03050658 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03050658 about?
NCT03050658 is a clinical study titled "Bathing Babies and Allergy". Atopic dermatitis (AD) is a chronic allergic skin disease with onset in early childhood and increasing prevalence in Westernized countries. Current well newborn guidelines for washing babies with soap were adopted by U.S. hospitals in the 1970s, before the rise in prevalence of allergic disease and ...
What is the current status of trial NCT03050658?
This trial is currently completed. The enrollment target is 28 participants. The study started on 2017-02-07. Estimated completion is 2021-05-31.
Who is sponsoring clinical trial NCT03050658?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.